Literature DB >> 11562008

Dangers and unreliability of mammography: breast examination is a safe, effective, and practical alternative.

S S Epstein1, R Bertell, B Seaman.   

Abstract

Mammography screening is a profit-driven technology posing risks compounded by unreliability. In striking contrast, annual clinical breast examination (CBE) by a trained health professional, together with monthly breast self-examination (BSE), is safe, at least as effective, and low in cost. International programs for training nurses how to perform CBE and teach BSE are critical and overdue.

Mesh:

Year:  2001        PMID: 11562008     DOI: 10.2190/2RHD-05T6-BRY0-1CEX

Source DB:  PubMed          Journal:  Int J Health Serv        ISSN: 0020-7314            Impact factor:   1.663


  3 in total

1.  Measurement of the knowledge level about breast self-exam among the female employees of a university hospital, Turkey.

Authors:  Hamide Şişman; Refiye Özgen; Dudu Baysal; Nuriye Sarıakçalı; Sibel Öztürk; Pınar Kum; Derya Gürel; Derya Kanarığ; Evren Aslaner; Yasemin Akıl; Meral Günaldı
Journal:  Asia Pac J Oncol Nurs       Date:  2014 Apr-Jun

2.  Overdetection of Breast Cancer.

Authors:  Martin J Yaffe; James G Mainprize
Journal:  Curr Oncol       Date:  2022-05-30       Impact factor: 3.109

3.  Applying ecological and evolutionary theory to cancer: a long and winding road.

Authors:  Frédéric Thomas; Daniel Fisher; Philippe Fort; Jean-Pierre Marie; Simon Daoust; Benjamin Roche; Christoph Grunau; Céline Cosseau; Guillaume Mitta; Stephen Baghdiguian; François Rousset; Patrice Lassus; Eric Assenat; Damien Grégoire; Dorothée Missé; Alexander Lorz; Frédérique Billy; William Vainchenker; François Delhommeau; Serge Koscielny; Raphael Itzykson; Ruoping Tang; Fanny Fava; Annabelle Ballesta; Thomas Lepoutre; Liliana Krasinska; Vjekoslav Dulic; Peggy Raynaud; Philippe Blache; Corinne Quittau-Prevostel; Emmanuel Vignal; Hélène Trauchessec; Benoit Perthame; Jean Clairambault; Vitali Volpert; Eric Solary; Urszula Hibner; Michael E Hochberg
Journal:  Evol Appl       Date:  2012-11-16       Impact factor: 5.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.